Open company graph database — free web & API
Login

Maruishi Pharmaceutical Co., Ltd.

丸石製薬株式会社
Ticker
—
Listed market
—
Country
Japan
Employees (consolidated)
491
Related companies
3
§01

Basic information

BASIC
Head office
4-2-4, Imazu-cho 2-chome, Tsurumi-ku, Osaka-shi, 538-0042
Chief executive
Capital
285,000,000  (2 100 million)
Employees (non-consolidated)
491 people
Employees (consolidated)
491 people
Start date
1936-11-05
End date
§02

Websites

1 DOMAINS
§03

Business

1
Manufacturing and sale of various pharmaceuticals and related products
§04

Related companies

3 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
General Incorporated Association Maruishi Pharmaceutical Health and Welfare Support Fund
Group
Mune Pharmaceuticals Co., Ltd.
General Incorporated Association for Appropriate Use of Drugs
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

44 EVENTS

Founded as Maruishi Shokai in Awajicho, Higashi-ku, OsakaSources

Maruishi Firm founded in Awajimachi, Higashi-ku, Osaka.Sources

Completion of Tenma factory in Kita-ku, Osaka as Maruishi Pharmaceutical GmBHSources

Temma Plant constructed in Kita-ku, Osaka, reorganizing into Maruishi Pharmaceutical unlimited partnership.Sources

Maruishi Pharmaceutical Co., Ltd. founded, capital 250,000 yenSources

Reorganized as a stock company (capital: ¥250,000), using the current name Maruishi Pharmaceutical Co., Ltd.Sources

Completion of Imazu factory in Joto-ku, Osaka (current location)Sources

Imazu Plant constructed in Imazucho, Joto-ku, Osaka (present location).Sources

Headquarters moved to Fushimi-cho, Higashiyama-ku, OsakaSources

Head office relocated to Fushimimachi, Higashi-ku, Osaka.Sources

Glutaral formulation Sterihyd® releasedSources

STERIHYDE® (disinfectant: glutaral preparation) launched.Sources

Central Research Institute completedSources

Construction of Central Research Laboratories completed.Sources

Fast-drying wipe hand sanitizer Wellpass® releasedSources

WELPAS® (disinfectant: alcohol-based hand rub) launched.Sources

General inhalation anesthetic Sevoflurane® releasedSources

SEVOFRANE® (inhalation: general anesthetic) launched.Sources

Capital increase to 285,000,000 yenSources

Capital increased to ¥285,000,000.Sources

New Central Research Institute building completedSources

Annex of Central Research Laboratories constructed.Sources

Sevoflurane FDA approval obtained in the United StatesSources

SEVOFLURANE approved from the US food and Drug Administration.Sources

Mekuro Research Institute incorporated as a subsidiarySources

Meguro Institute Co, Ltd. became a subsidiary.Sources

New headquarters building (head office) completed at Imazu, Tsurumi-ku, Osaka CitySources

New head office building constructed in Imazu, Tsurumi-ku, Osaka.Sources

Company-wide organizational reform implementedSources

Organizational changes implemented.Sources

α2-agonist sedative Presedex® releasedSources

PRECEDEX® (sedative: alpha-2 adrenergic agonists) launched.Sources

Long-acting local anesthetic Popskine® releasedSources

POPSCAINE® (long-acting local anesthetic) launched.Sources

Fast-drying wipe hand sanitizer Wellsept® releasedSources

WELCEPT® (disinfectant: alcohol-based hand rub) launched.Sources

Foam fast-drying hand sanitizer Wellform® releasedSources

WELFOAM® (disinfectant: foaming alcohol-based hand rub) launched.Sources

Head office location changed to Imatsu, Tsurumi-ku, OsakaSources

Corporate domicile changed to Imazu, Tsurumi-ku, Osaka.Sources

Imazu Plant Special Drug Building completedSources

Warehouse for specific drugs at Imazu Plant constructed.Sources

Mekuro Research Institute transferred to Teijin CorporationSources

Transferred Meguro Institute Co., Ltd. to Teijin Limited.Sources

§07

News

0 ARTICLES

There is no news.

§08

Public records

GOV
National Tax Agency basic information8120001089922
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
丸石製薬株式会社
Trade name (kana)
マルイシセイヤク
Name in English
Corporation type
301
Address
〒538-0042 大阪府大阪市鶴見区今津中2丁目4番2号
Postal code
5380042
Prefecture code
27
City code
124
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2019-06-25
Change date
2015-10-05
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
1
Trade name image ID
Address image ID
Sequence number
4361631
METI gBizINFO8120001089922
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
8120001089922
Trade name
丸石製薬株式会社
Trade name (kana)
マルイシセイヤク
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
大阪府大阪市鶴見区今津中2丁目4番2号
Postal code
5380042
Prefecture
大阪府
Prefecture code
27
City or district
大阪市鶴見区
City code
124
Street address
今津中2丁目4番2号
Organisation type
301
Processing type
01
Correction type
1
Status
Representative
Capital
Employees
502
Employees (male)
Employees (female)
Business summary
周術期領域、殺菌・消毒領域および日本薬局方医薬品領域を中心とする医薬品の研究・開発・製造・販売
Website URL
http://www.maruishi-pharm.co.jp/
Year founded
Business category
E:製造業
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2019-06-25
Key information
8120001089922
§09

Sources & updates

SOURCES
↑